Archives for September 30, 2009

← 2009

Sun says Taro suit is “baseless litigation”

By Gareth Macdonald

Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family in their ongoing refusal to comply with their...

Forenap wins Anavex 2-73 Ph I trial contract

French neuroscience CRO Forenap Pharma has won the contract to conduct Phase I trials of an Alzheimer’s disease treatment candidate being developed by Swiss drugmaker Anavex Life Sciences.

Kendle using OmniComm’s TrialMaster

By Staff reporter

Kendle has added OmniComm’s TrialMaster electronic data capture (EDC) technology to its eClinical offering in a multi-year enterprise-wide agreement.

Inclinix to boost recruitment for US Diamyd vacc trial

By Gareth Macdonald

Diabetes focused drugmaker Diamyd Medical has called in CRO Inclinix Medical to help recruit patients for “rapidly expanding” late-stage trials of its candidate diabetes vaccine Diamyd.

AAHRPP revises standards

By Nick Taylor

The AAHRPP has issued a major revision of its standards, the first time it has done so, adding sections on transnational research and the separation of business interests from ethics review.

Ash Stevens starts $6m expansion

By Nick Taylor

Buoyed by an increase in repeat business and deals with large pharma companies Ash Stevens has begun a $6m (€4.1m) expansion of its API manufacturing facility, with further phases planned to occur over the next six years.

MDS’ sites gain Brazilian regulatory certification

By Nick Taylor

MDS Pharma Services has become the first CRO in the UK and second in the US to gain certification from the Brazilian regulatory agency after a “major client” requested it sought accreditation.